StonvexLoading…
StonvexStonvexStonvexCore line items from APYX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $52.84M | $48.10M | $52.35M | $44.51M |
Operating Income | $-6.45M | $-18.84M | $-17.26M | $-23.56M |
Net Income | $-11.21M | $-23.46M | $-18.71M | $-23.18M |
EPS (Diluted) | $-0.27 | $-0.66 | $-0.54 | $-0.67 |
Total Assets | $66.84M | $64.84M | $79.24M | $51.77M |
Total Liabilities | $52.01M | $50.51M | $52.32M | $13.98M |
Cash & Equivalents | $31.74M | $31.74M | $43.65M | $10.19M |
Free Cash Flow OCF − CapEx | $-9.12M | $-18.77M | $-5.78M | $-21.29M |
Shares Outstanding | 41.79M | 37.79M | 34.64M | 34.60M |